Mengyuan Fu

Also affiliated with Peking University, Yale University, Peking University International Hospital

Immunology and MicrobiologyMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis”.

Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis

The Lancet Oncology(2025)10.1016/s1470-2045(25)00329-8

N/A

0DataRank · unranked

9 citations

Dingyi Chen, Mengyuan Fu, Luwen Shi, Huseyin Naci, Anita K. Wagner +3 more

Access to Information Cited in National Organization for Rare Disorders Reports

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.11758

N/A

0DataRank · unranked

2 citations

K. C. Ling, Xinyi Zhou, Sneha Dave, Can Li, Luwen Shi +3 more